Exendin‐4 improves cardiovascular function and survival in flow‐induced pulmonary hypertension

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jtcvs.2017.10.085PMID 29249493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased understanding leads to increased complexity: Molecular mechanisms of pulmonary arterial hypertension.

  2016cited by this paper
• Spinal cord injury enhances arterial expression and reactivity of α1-adrenergic receptors-mechanistic investigation into autonomic dysreflexia.

  2016cited by this paper
• Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes.

  2016cited by this paper
• Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic-pathophysiologic classification.

  2016cited by this paper
• Update in treatment options in pulmonary hypertension.

  2016cited by this paper
• Pulmonary arterial hypertension: the burden of disease and impact on quality of life

  2015cited by this paper
• [Updated clinical classification of pulmonary hypertension].

  2014cited by this paper
• Inflammatory cytokines in pulmonary hypertension

  2014influential reference
• Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.

  2014cited by this paper
• Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

  2014influential reference
• Rosuvastatin Suppresses the Oxidative Response in the Venous Limb of an Arteriovenous Fistula and Enhances the Fistula Blood Flow in Diabetic Rats

  2014cited by this paper
• Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid prevents the development of hypoxia-induced pulmonary arterial hypertension.

  2014cited by this paper
• Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.

  2013cited by this paper
• Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease Alcohol Intake and Reward

  2013cited by this paper
• PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury

  2013cited by this paper
• Cardiovascular Protection of Activating KATP Channel During Ischemia-Reperfusion Acidosis

  2012cited by this paper
• Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.

  2012influential reference
• Inhibition of cyclooxygenase-2 modulates phenotypic switching of vascular smooth muscle cells during increased aortic blood flow

  2012cited by this paper
• Glucagon‐like peptide‐1‐based therapies and cardiovascular disease: looking beyond glycaemic control

  2011cited by this paper
• Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes.

  2011cited by this paper
• Transplantation of Endothelial Progenitor Cells Improves Pulmonary Endothelial Function and Gas Exchange in Rabbits with Endotoxin-Induced Acute Lung Injury

  2011cited by this paper
• Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats

  2011cited by this paper
• Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4

  2010cited by this paper
• Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor.

  2010cited by this paper
• Updated clinical classification of pulmonary hypertension.

  2009cited by this paper
• Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.

  2009cited by this paper
• IL-1beta, BK, and TGF-beta1 attenuate PGI2-mediated cAMP formation in human pulmonary artery smooth muscle cells by multiple mechanisms involving p38 MAP kinase and PKA.

  2008cited by this paper
• Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

  2008cited by this paper
• A Specific Role for eNOS-Derived Reactive Oxygen Species in Atherosclerosis Progression

  2007cited by this paper
• Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease

  2006cited by this paper
• Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension.

  2005influential reference
• The role of increased pulmonary blood flow in pulmonary arterial hypertension

  2005influential reference
• Roles of Hemodynamic Forces in Vascular Cell Differentiation

  2005influential reference
• Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

  2004cited by this paper
• Pacing‐Induced Dilated Cardiomyopathy Increases Left‐to‐RightVentricular Systolic Interaction

  1993cited by this paper
• Pulmonary vascular disease with congenital heart lesions: pathologic features and causes.

  1981cited by this paper

• The Anti-Fibrotic Potential of GLP-1 and GIP Receptor Agonists in Chronic Inflammatory Disorders: Mechanisms and Therapeutic Horizons

  2026cites this paper
• Glucagon-like peptide-1 receptor modulates cerebrospinal fluid secretion and intracranial pressure in rats

  2025cites this paper
• Therapeutic Potential of GLP-1 Receptor Agonists in Diabetes and Cardiovascular Disease: Mechanisms and Clinical Implications

  2025cites this paper
• Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?

  2024cites this paper
• Exendin-4, a glucagon-like peptide-1 receptor agonist, regulates ductus arteriosus by vasodilation and anti-remodeling through the PKA pathway.

  2024cites this paper
• Radiomic and quantitative-semantic models of low-dose computed tomography for predicting the poorly differentiated invasive non-mucinous pulmonary adenocarcinoma

  2023cites this paper
• The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms.

  2023cites this paper
• Comparison of the effects of exenatide and insulin glargine on right and left ventricular myocardial deformation as shown by 2D-speckle-tracking echocardiograms

  2022cites this paper
• Prothymosin α Gene Transfer Modulates Myocardial Remodeling after Ischemia-Reperfusion Injury.

  2022cites this paper
• GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes

  2022cites this paper
• Beneficial Influence of Exendin-4 on Specific Organs and Mechanisms Favourable for the Elderly with Concomitant Obstructive Lung Diseases

  2022cites this paper
• Rosuvastatin Failed to Improve Arteriovenous Fistula Patency for Hemodialysis in Diabetic Patients - A Randomized Clinical Trial.

  2021cites this paper
• Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes

  2021cites this paper
• Transplantation of viable mitochondria improves right ventricular performance and pulmonary artery remodeling in rats with pulmonary arterial hypertension.

  2020cites this paper
• ProT-α gene transfer attenuates cardiopulmonary remedying and mortality in a flow-induced pulmonary hypertension rat model.

  2020cites this paper
• Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway.

  2018cites this paper
• Pulmonary vascular dysfunction in metabolic syndrome

  2018cites this paper
• Initium novum?

  2018cites this paper